Litcius/Paper detail

Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease

Raysa S. Farias, Rodrigo P. Silva‐Aguiar, Douglas E. Teixeira, Carlos Perez Gomes, Ana Acácia S. Pinheiro, Diogo B. Peruchetti, Celso Caruso‐Neves

2023European Journal of Pharmacology29 citationsDOI

Topics & Concepts

AlbuminuriaReabsorptionInternal medicineProteinuriaEndocrinologyRenal functionDapagliflozinDiabetic nephropathyStreptozotocinMedicineKidneyTubuleDiabetes mellitusKidney diseaseChemistryType 2 diabetesDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesPancreatic function and diabetes
Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease | Litcius